HomeCompareGHSI vs GIS

GHSI vs GIS: Dividend Comparison 2026

GHSI yields 615.38% · GIS yields 6.53%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GHSI wins by $317096.76M in total portfolio value
10 years
GHSI
GHSI
● Live price
615.38%
Share price
$3.25
Annual div
$20.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$317096.84M
Annual income
$240,286,389,158.92
Full GHSI calculator →
GIS
GIS
● Live price
6.53%
Share price
$37.22
Annual div
$2.43
5Y div CAGR
22.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.8K
Annual income
$16,211.26
Full GIS calculator →

Portfolio growth — GHSI vs GIS

📍 GHSI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGHSIGIS
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GHSI + GIS cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GHSI pays
GIS pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GHSI
Annual income on $10K today (after 15% tax)
$52,307.69/yr
After 10yr DRIP, annual income (after tax)
$204,243,430,785.08/yr
GIS
Annual income on $10K today (after 15% tax)
$554.94/yr
After 10yr DRIP, annual income (after tax)
$13,779.57/yr
At 15% tax rate, GHSI beats the other by $204,243,417,005.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GHSI + GIS for your $10,000?

GHSI: 50%GIS: 50%
100% GIS50/50100% GHSI
Portfolio after 10yr
$158548.46M
Annual income
$120,143,202,685.09/yr
Blended yield
75.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GIS right now

GHSI
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Price Target
$0.01
-99.6% upside vs current
Range: $0.01 — $0.01
Altman Z
-5.6
Piotroski
5/9
GIS
Analyst Ratings
9
Buy
19
Hold
6
Sell
Consensus: Hold
Price Target
$47.42
+27.4% upside vs current
Range: $35.00 — $63.00
Altman Z
2.2
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GHSI buys
0
GIS buys
0
No recent congressional trades found for GHSI or GIS in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGHSIGIS
Forward yield615.38%6.53%
Annual dividend / share$20.00$2.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.8%
Portfolio after 10y$317096.84M$78.8K
Annual income after 10y$240,286,389,158.92$16,211.26
Total dividends collected$310719.17M$50.8K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold
Analyst price target$0.01$47.42

Year-by-year: GHSI vs GIS ($10,000, DRIP)

YearGHSI PortfolioGHSI Income/yrGIS PortfolioGIS Income/yrGap
1← crossover$72,238$61,538.46$11,502$801.73+$60.7KGHSI
2$492,757$415,462.04$13,365$1,058.29+$479.4KGHSI
3$3,175,824$2,648,573.62$15,712$1,411.34+$3.16MGHSI
4$19,351,474$15,953,343.00$18,716$1,904.17+$19.33MGHSI
5$111,556,214$90,850,136.77$22,629$2,603.16+$111.53MGHSI
6$608,830,006$489,464,856.28$27,826$3,612.21+$608.80MGHSI
7$3,147,996,660$2,496,548,553.59$34,871$5,097.54+$3147.96MGHSI
8$15,432,443,240$12,064,086,814.21$44,643$7,331.52+$15432.40MGHSI
9$71,785,467,937$55,272,753,670.42$58,541$10,772.15+$71785.41MGHSI
10$317,096,839,852$240,286,389,158.92$78,850$16,211.26+$317096.76MGHSI

GHSI vs GIS: Complete Analysis 2026

GHSIStock

Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It also provides MapcatSF, a medical device that measures the macular pigment optical density; CSV-1000 device that offers auto-calibrated tests to ensure the correct testing luminance and contrast levels; and CSV-2000, a digital standardized contrast sensitivity testing device, as well as develops, manufactures, and sells equipment and supplies for standardized vision testing under the VectorVision name for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing. In addition, the company develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.

Full GHSI Calculator →

GISConsumer Staples

General Mills, Inc. manufactures and markets branded consumer foods worldwide. The company operates in five segments: North America Retail; Convenience Stores & Foodservice; Europe & Australia; Asia & Latin America; and Pet. It offers ready-to-eat cereals, refrigerated yogurt, soup, meal kits, refrigerated and frozen dough products, dessert and baking mixes, bakery flour, frozen pizza and pizza snacks, snack bars, fruit and salty snacks, ice cream, nutrition bars, wellness beverages, and savory and grain snacks, as well as various organic products, including frozen and shelf-stable vegetables. It also supplies branded and unbranded food products to the North American foodservice and commercial baking industries; and manufactures and markets pet food products, including dog and cat food. The company markets its products under the Annie's, Betty Crocker, Bisquick, Blue Buffalo, Blue Basics, Blue Freedom, Bugles, Cascadian Farm, Cheerios, Chex, Cinnamon Toast Crunch, Cocoa Puffs, Cookie Crisp, EPIC, Fiber One, Food Should Taste Good, Fruit by the Foot, Fruit Gushers, Fruit Roll-Ups, Gardetto's, Go-Gurt, Gold Medal, Golden Grahams, Häagen-Dazs, Helpers, Jus-Rol, Kitano, Kix, Lärabar, Latina, Liberté, Lucky Charms, Muir Glen, Nature Valley, Oatmeal Crisp, Old El Paso, Oui, Pillsbury, Progresso, Raisin Nut Bran, Total, Totino's, Trix, Wanchai Ferry, Wheaties, Wilderness, Yoki, and Yoplait trademarks. It sells its products directly, as well as through broker and distribution arrangements to grocery stores, mass merchandisers, membership stores, natural food chains, e-commerce retailers, commercial and noncommercial foodservice distributors and operators, restaurants, convenience stores, and pet specialty stores, as well as drug, dollar, and discount chains. The company operates 466 leased and 392 franchise ice cream parlors. General Mills, Inc. was founded in 1866 and is headquartered in Minneapolis, Minnesota.

Full GIS Calculator →
📬

Get this GHSI vs GIS comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GHSI vs SCHDGHSI vs JEPIGHSI vs OGHSI vs KOGHSI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.